BRPI0816317A2 - Método para tratar o estresse oxidativo e melhorar a memória de trabalho pela administração de pterostilbeno - Google Patents
Método para tratar o estresse oxidativo e melhorar a memória de trabalho pela administração de pterostilbenoInfo
- Publication number
- BRPI0816317A2 BRPI0816317A2 BRPI0816317A BRPI0816317A BRPI0816317A2 BR PI0816317 A2 BRPI0816317 A2 BR PI0816317A2 BR PI0816317 A BRPI0816317 A BR PI0816317A BR PI0816317 A BRPI0816317 A BR PI0816317A BR PI0816317 A2 BRPI0816317 A2 BR PI0816317A2
- Authority
- BR
- Brazil
- Prior art keywords
- pterostilbene
- working memory
- oxidative stress
- subject
- improve working
- Prior art date
Links
- VLEUZFDZJKSGMX-UHFFFAOYSA-N pterostilbene Natural products COC1=CC(OC)=CC(C=CC=2C=CC(O)=CC=2)=C1 VLEUZFDZJKSGMX-UHFFFAOYSA-N 0.000 title abstract 6
- VLEUZFDZJKSGMX-ONEGZZNKSA-N pterostilbene Chemical compound COC1=CC(OC)=CC(\C=C\C=2C=CC(O)=CC=2)=C1 VLEUZFDZJKSGMX-ONEGZZNKSA-N 0.000 title abstract 4
- 230000003936 working memory Effects 0.000 title abstract 4
- 230000036542 oxidative stress Effects 0.000 title abstract 3
- 230000037396 body weight Effects 0.000 abstract 2
- -1 pterostilbene compound Chemical class 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Psychiatry (AREA)
- Toxicology (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
MÉTODO PARA TRATAR O ESTRESSE OXIDATIVO E MELHORAR A MEMÓRIA DE TRABALHO PELA ADMINISTRAÇÃO DE PTEROSTILBENO. É revelada uma composição farmacêutica para tratar estresse oxidativo compreendendo uma quantidade terapeuticamente eficaz de um composto substancialmente puro de pterostilbeno e um carreador fisiologicamente aceitável. O pterostilbeno é administrado em uma quantidade entre aproximadamente 2,5 mg a aproximadamente 10 mg por quilograma de peso corporal do indivíduo. É revelado também um método para aumentar a memória de trabalho de um indivíduo, o método compreendendo a administração de uma quantidade eficaz de um composto substancialmente puro de pterostilbeno, no qual a memória de trabalho para um indivíduo aumenta e a eficácia terapêutica é de aproximadamente 10 mg de pterostilbeno por quilograma de peso corporal do indivíduo.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97059107P | 2007-09-07 | 2007-09-07 | |
| US12/136,341 US20090069444A1 (en) | 2007-09-07 | 2008-06-10 | Method to Ameliorate Oxidative Stress and Improve Working Memory Via Pterostilbene Administration |
| PCT/US2008/075170 WO2009032870A2 (en) | 2007-09-07 | 2008-09-04 | Method to ameliorate oxidative stress and improve working memory via pterostilbene administration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0816317A2 true BRPI0816317A2 (pt) | 2017-07-25 |
Family
ID=40429677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0816317A BRPI0816317A2 (pt) | 2007-09-07 | 2008-09-04 | Método para tratar o estresse oxidativo e melhorar a memória de trabalho pela administração de pterostilbeno |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20090069444A1 (pt) |
| EP (1) | EP2200597B1 (pt) |
| JP (1) | JP5608082B2 (pt) |
| KR (1) | KR20100075468A (pt) |
| CN (2) | CN101820869B (pt) |
| AU (1) | AU2008296293A1 (pt) |
| BR (1) | BRPI0816317A2 (pt) |
| CA (1) | CA2698661C (pt) |
| ES (1) | ES2526648T3 (pt) |
| WO (1) | WO2009032870A2 (pt) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090069444A1 (en) * | 2007-09-07 | 2009-03-12 | The United States Of America, As Represented By Th E Secretary Of Agriculture | Method to Ameliorate Oxidative Stress and Improve Working Memory Via Pterostilbene Administration |
| ES2798254T3 (es) * | 2009-06-22 | 2020-12-10 | Indus Biotech Private Ltd | Proceso para la obtención de pteroestilbeno purificado y métodos de uso del mismo |
| US20100119499A1 (en) * | 2009-09-17 | 2010-05-13 | Kneller Bruce W | Stilbene-based compositions and methods of use therefor |
| US20110280850A1 (en) * | 2010-05-12 | 2011-11-17 | Starr Elizabeth I | Compositions Containing DNA Repair Enzyme And Anogeissus Extract |
| US20120237494A1 (en) * | 2010-09-30 | 2012-09-20 | Daly Susan M | Compositions Containing Zinc PCA And Anogeissus Extract |
| EP2537513A3 (en) * | 2011-03-11 | 2015-04-29 | ELC Management LLC | Use of anogeissus extract for fibrillin production in skin |
| US9439875B2 (en) * | 2011-05-11 | 2016-09-13 | The United States Of America, As Represented By The Secretary Of Agriculture | Anxiolytic effect of pterostilbene |
| US20130072509A1 (en) * | 2011-09-15 | 2013-03-21 | ChromaDex Inc. | Pterostilbene and statin combination for treatment of metabolic disease, cardiovascular disease, and inflammation |
| WO2013051459A1 (ja) * | 2011-10-02 | 2013-04-11 | キユーピー 株式会社 | ＲＮＡ干渉によるｍＲＮＡ発現の抑制を促進する促進剤およびその用途 |
| JP5901547B2 (ja) | 2012-03-28 | 2016-04-13 | 富士フイルム株式会社 | 組成物、これを含む皮膚外用剤、又は機能性食品 |
| CN109985056A (zh) | 2013-10-30 | 2019-07-09 | 可劳迈戴斯有限公司 | 用于在治疗皮肤病中局部使用的烟酰胺核苷组合物 |
| US20190076376A1 (en) | 2015-07-10 | 2019-03-14 | University Of Miami | Methods for treating mucopolysaccharidosis |
| KR20190046895A (ko) | 2016-08-22 | 2019-05-07 | 엘리시움 헬스, 인크. | 신경퇴행성 질환의 치료를 위한 니코틴아미드 리보사이드 및 프테로스틸렌 조성물 및 방법 |
| EP3538099A4 (en) | 2016-11-11 | 2020-06-17 | The Queen's University of Belfast | EFFICIENT AND SCALABLE SYNTHESIS OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, MODIFIED DERIVATIVES THEREOF, PHOSPHORYLATED ANALOGS OF THEM, ADENYLYDINUCLEOTIDE CONJUGATES THEREOF AND NEW-WAY CRYSTALS |
| US11633421B2 (en) | 2016-11-29 | 2023-04-25 | University Of Iowa Research Foundation | Use of NAD precursors for improving maternal health and/or offspring health |
| US11071747B2 (en) | 2016-11-29 | 2021-07-27 | University Of Iowa Research Foundation | Use of NAD precursors for breast enhancement |
| WO2019222265A1 (en) | 2018-05-15 | 2019-11-21 | Alkahest, Inc. | Treatment of aging-associated disease with modulators of leukotriene a4 hydrolase |
| JP7345312B2 (ja) * | 2019-08-09 | 2023-09-15 | キユーピー株式会社 | 発酵乳 |
| KR102718991B1 (ko) * | 2020-09-25 | 2024-10-16 | 씨제이제일제당 (주) | 스틸벤계 화합물을 포함하는 항콕시듐증 조성물 및 이의 용도 |
| CN112618520A (zh) * | 2021-01-14 | 2021-04-09 | 姚大纯 | 紫檀芪或白藜芦醇在制备用于治疗或改善孤独症谱系障碍的药物中的应用 |
| WO2023076679A1 (en) | 2021-11-01 | 2023-05-04 | Alkahest, Inc. | Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging-associated diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050038125A1 (en) * | 2003-08-15 | 2005-02-17 | Smit Hobbe Friso | Method for the treatment of arthritis and pain |
| JP4633572B2 (ja) * | 2004-07-30 | 2011-02-16 | イスクラ産業株式会社 | 糖尿病改善剤 |
| WO2006020999A2 (en) * | 2004-08-19 | 2006-02-23 | The United States Of America, As Represented By The Secretary Of Agriculture | Pterostilbene as a new agonist for the peroxisome proliferator-activated receptor alpha isoform |
| US20090069444A1 (en) * | 2007-09-07 | 2009-03-12 | The United States Of America, As Represented By Th E Secretary Of Agriculture | Method to Ameliorate Oxidative Stress and Improve Working Memory Via Pterostilbene Administration |
-
2008
- 2008-06-10 US US12/136,341 patent/US20090069444A1/en not_active Abandoned
- 2008-09-04 JP JP2010524125A patent/JP5608082B2/ja not_active Expired - Fee Related
- 2008-09-04 CN CN2008801103188A patent/CN101820869B/zh active Active
- 2008-09-04 BR BRPI0816317A patent/BRPI0816317A2/pt not_active IP Right Cessation
- 2008-09-04 WO PCT/US2008/075170 patent/WO2009032870A2/en active Application Filing
- 2008-09-04 AU AU2008296293A patent/AU2008296293A1/en not_active Abandoned
- 2008-09-04 KR KR20107007002A patent/KR20100075468A/ko not_active Ceased
- 2008-09-04 EP EP20080799127 patent/EP2200597B1/en active Active
- 2008-09-04 CN CN201210421008.6A patent/CN103083288B/zh active Active
- 2008-09-04 CA CA2698661A patent/CA2698661C/en active Active
- 2008-09-04 ES ES08799127.9T patent/ES2526648T3/es active Active
-
2011
- 2011-08-08 US US13/204,891 patent/US8809400B2/en active Active
-
2014
- 2014-05-22 US US14/284,901 patent/US9028887B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010538077A (ja) | 2010-12-09 |
| WO2009032870A2 (en) | 2009-03-12 |
| HK1148932A1 (en) | 2011-09-23 |
| WO2009032870A3 (en) | 2009-05-22 |
| US20140256827A1 (en) | 2014-09-11 |
| EP2200597A2 (en) | 2010-06-30 |
| ES2526648T3 (es) | 2015-01-14 |
| AU2008296293A1 (en) | 2009-03-12 |
| EP2200597A4 (en) | 2010-09-08 |
| US8809400B2 (en) | 2014-08-19 |
| CA2698661C (en) | 2016-03-29 |
| US20090069444A1 (en) | 2009-03-12 |
| US9028887B2 (en) | 2015-05-12 |
| CN101820869A (zh) | 2010-09-01 |
| JP5608082B2 (ja) | 2014-10-15 |
| EP2200597B1 (en) | 2014-11-12 |
| CA2698661A1 (en) | 2009-03-12 |
| US20120035272A1 (en) | 2012-02-09 |
| CN103083288A (zh) | 2013-05-08 |
| CN101820869B (zh) | 2012-12-12 |
| KR20100075468A (ko) | 2010-07-02 |
| HK1185257A1 (zh) | 2014-02-14 |
| CN103083288B (zh) | 2016-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0816317A2 (pt) | Método para tratar o estresse oxidativo e melhorar a memória de trabalho pela administração de pterostilbeno | |
| NI201100147A (es) | Métodos para tratar infartos agudos de miocardio y trastornos relacionados. | |
| CO6160321A2 (es) | Uso de 2-6-(3-amino-piperidin-1-il)-3-metil-2,4-dioxo-3,4-dihidro-2h-pirimidin-1-ilmetil-4-fluoro-benzonitrilo | |
| CO6150188A2 (es) | Uso de teencteplasa para tratar un ictus isquemico agudo | |
| NI201100100A (es) | Moduladores de aril metil benzoquinazolinona alostéricos positivos del receptor m1. | |
| UY35624A (es) | Uso de dosis elevadas de pridopidina para tratar la enfermedad de huntington | |
| AR070047A1 (es) | Tratamientos terapeuticos contra el cancer. composicion que comprende un inhibidor de hedgehog. | |
| RU2015107877A (ru) | Способы лечения болезни альцгеймера и фармацевтические композиции | |
| UA105644C2 (uk) | Способи лікування легеневих порушень складами ліпосомального амікацину | |
| ECSP066878A (es) | [hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa | |
| AR082803A1 (es) | Metodos y formulaciones para el tratamiento de la trombosis con betrixaban y un inhibidor de la glicoproteina p | |
| CA2632207C (en) | Use of calcitonin for the treatment of ra | |
| NZ595376A (en) | Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration | |
| AR012256A1 (es) | Procedimiento para el tratamiento de la resistencia a la insulina en un mamifero, composiciones farmaceuticas, procedimiento para aumentar los nivelesde hormona de crecimiento endogena, procedimiento para el tratamiento o prevencion de la insuficiencia cardiaca congestiva, obesidad o debilidad | |
| ES2570401T3 (es) | Métodos de tratamiento usando dosis únicas de oritavancina | |
| EA200700214A1 (ru) | Мемантин в качестве дополнительной терапии к атипичным антипсихотическим средствам у больных шизофренией | |
| MX2011011058A (es) | Antagonistas del receptor ep4 para el tratamiento de cancer. | |
| AR061233A1 (es) | Formulacion de liberacion prolongada de naltrexona | |
| UA92498C2 (ru) | Каннабиноидно активный фармацевтический ингредиент для улучшенных дозированных форм | |
| MX2007010886A (es) | Metodos y formulaciones de acarbosa para tratar constipacion cronica. | |
| MX341660B (es) | Agonista del receptor de ghrelina para el tratamiento de caquexia. | |
| CL2024003616A1 (es) | Composición farmacéutica oral y uso para la terapia de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| TNSN06072A1 (en) | Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep | |
| NZ587941A (en) | Methods to inhibit tumor cell growth by using lansoprazole | |
| CA2516458A1 (en) | Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |